BIO calls for approval of biotech salmon

05/1/2013 | BiofuelsDigest.com

BIO encouraged the FDA to approve AquaBounty Technologies' AquAdvantage biotech salmon, saying that all scientific steps required for regulatory approval have been completed. "This evaluation has been thorough. It is past time to provide a decision and let the market determine whether it supports this innovation that produces healthy food in a sustainable manner by using inland farms to help us meet global protein needs," said David Edwards, BIO's director of animal biotechnology.

View Full Article in:

BiofuelsDigest.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Director, Payer Marketing
Avalere Health
Washington, DC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX